Jakubauskiene, L.; Jakubauskas, M.; Razanskiene, G.; Leber, B.; Weber, J.; Rohrhofer, L.; Ramasauskaite, D.; Strupas, K.; Stiegler, P.; Schemmer, P.
Relaxin and Erythropoietin Significantly Reduce Uterine Tissue Damage during Experimental Ischemia–Reperfusion Injury. Int. J. Mol. Sci. 2022, 23, 7120.
https://doi.org/10.3390/ijms23137120
AMA Style
Jakubauskiene L, Jakubauskas M, Razanskiene G, Leber B, Weber J, Rohrhofer L, Ramasauskaite D, Strupas K, Stiegler P, Schemmer P.
Relaxin and Erythropoietin Significantly Reduce Uterine Tissue Damage during Experimental Ischemia–Reperfusion Injury. International Journal of Molecular Sciences. 2022; 23(13):7120.
https://doi.org/10.3390/ijms23137120
Chicago/Turabian Style
Jakubauskiene, Lina, Matas Jakubauskas, Gintare Razanskiene, Bettina Leber, Jennifer Weber, Lisa Rohrhofer, Diana Ramasauskaite, Kestutis Strupas, Philipp Stiegler, and Peter Schemmer.
2022. "Relaxin and Erythropoietin Significantly Reduce Uterine Tissue Damage during Experimental Ischemia–Reperfusion Injury" International Journal of Molecular Sciences 23, no. 13: 7120.
https://doi.org/10.3390/ijms23137120
APA Style
Jakubauskiene, L., Jakubauskas, M., Razanskiene, G., Leber, B., Weber, J., Rohrhofer, L., Ramasauskaite, D., Strupas, K., Stiegler, P., & Schemmer, P.
(2022). Relaxin and Erythropoietin Significantly Reduce Uterine Tissue Damage during Experimental Ischemia–Reperfusion Injury. International Journal of Molecular Sciences, 23(13), 7120.
https://doi.org/10.3390/ijms23137120
